Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People whose general health and ability to carry out daily activities meets a minimum functional threshold (known as a Karnofsky Performance Status score of 60 or above — confirm with trial site if unsure what this means for a specific situation)
- People whose cancer has been confirmed through a tissue sample (biopsy or similar laboratory testing)
- People whose MRI scan shows signs of brain metastases (cancer that has spread to the brain)
- People who have one brain metastasis that doctors have recommended for surgical removal, and any other brain metastases that are suitable for a focused radiation treatment called stereotactic radiotherapy
- People whose main target brain metastasis measures between 1 cm and 7 cm at its longest point on a specific type of MRI scan (T1 post-contrast imaging)
Who may not be able to join:
- People whose cancer is a blood cancer (such as leukaemia or lymphoma)
- People with small-cell lung carcinoma (a specific type of lung cancer)
- People experiencing a sudden, severe neurological emergency requiring immediate brain surgery
- People who have previously had whole-brain radiotherapy
- People who have previously had stereotactic radiotherapy directed at the brain metastasis being targeted in this trial
- People who are pregnant
- People for whom surgery on the target brain metastasis cannot be performed within 7 days after the pre-surgical radiation treatment used in this trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jakub Cvek, Assoc.Prof., MD, Ing, PhD, MBA, University Hospital Ostrava
Phone: 0042059737
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute Toxicity; Quality of Life Questionnaire (FACT-Br/EORTC QLQ-C30); Quality of Life Questionnaire (EORTC QLQ-BN20)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.